These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 10627638)
1. Second marrow transplants for graft failure in patients with thalassemia. Gaziev D; Polchi P; Lucarelli G; Galimberti M; Sodani P; Angelucci E; Giardini C; Baronciani D; Erer B Bone Marrow Transplant; 1999 Dec; 24(12):1299-306. PubMed ID: 10627638 [TBL] [Abstract][Full Text] [Related]
2. Bone marrow transplantation in thalassemia major patients using "short" anti-thymocyte globulin therapy in Shiraz, Southern Iran. Zakerinia M; Khojasteh HN; Ramzi M; Haghshenas M Transplant Proc; 2005 Dec; 37(10):4477-81. PubMed ID: 16387149 [TBL] [Abstract][Full Text] [Related]
3. Bone marrow transplantation in adults with thalassemia: Treatment and long-term follow-up. Gaziev J; Sodani P; Polchi P; Andreani M; Lucarelli G Ann N Y Acad Sci; 2005; 1054():196-205. PubMed ID: 16339666 [TBL] [Abstract][Full Text] [Related]
4. Second hematopoietic SCT in patients with thalassemia recurrence following rejection of the first graft. Gaziev J; Sodani P; Lucarelli G; Polchi P; Marktel S; Paciaroni K; Marziali M; Isgrò A; Simone MD; Roveda A; Montuoro A; Lanti A; Alfieri C; De Angelis G; Gallucci C; Ciceri F; Roncarolo MG Bone Marrow Transplant; 2008 Sep; 42(6):397-404. PubMed ID: 18574445 [TBL] [Abstract][Full Text] [Related]
5. Second allogeneic bone marrow transplantation after myeloablative conditioning analysis of 43 cases from single institution. Al-Qurashi F; Ayas M; Al Sharif F; Ibrahim E; Sahovic E; Al Mahr M; Chaudhri N; Al Mohareb F; Al Zahrani H; Al Jefri A; Al Omar H; Al Shanqeeti A; Seth P; Aslam M; El Solh H; Aljurf M Hematology; 2004 Apr; 9(2):123-9. PubMed ID: 15203867 [TBL] [Abstract][Full Text] [Related]
6. Paediatric allogeneic bone marrow transplantation for homozygous beta-thalassaemia, the Dutch experience. Ball LM; Lankester AC; Giordano PC; van Weel MH; Harteveld CL; Bredius RG; Smiers FJ; Egeler RM; Vossen JM Bone Marrow Transplant; 2003 Jun; 31(12):1081-7. PubMed ID: 12796787 [TBL] [Abstract][Full Text] [Related]
7. Unrelated bone marrow transplantation for beta-thalassemia patients: The experience of the Italian Bone Marrow Transplant Group. La Nasa G; Argiolu F; Giardini C; Pession A; Fagioli F; Caocci G; Vacca A; De Stefano P; Piras E; Ledda A; Piroddi A; Littera R; Nesci S; Locatelli F Ann N Y Acad Sci; 2005; 1054():186-95. PubMed ID: 16339665 [TBL] [Abstract][Full Text] [Related]
8. Bone marrow transplantation for severe aplastic anemia: the Barcelona Hospital Clinic experience. Hernández-Boluda JC; Marín P; Carreras E; Aguilar JL; Grañena A; Rozman C; Montserrat E Haematologica; 1999 Jan; 84(1):26-31. PubMed ID: 10091390 [TBL] [Abstract][Full Text] [Related]
9. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia. Mengarelli A; Iori A; Guglielmi C; Romano A; Cerretti R; Torromeo C; Micozzi A; Fenu S; Laurenti L; Donato V; De Felice L; Arcese W Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465 [TBL] [Abstract][Full Text] [Related]
10. Marrow transplantation in patients with advanced thalassemia. Lucarelli G; Galimberti M; Polchi P; Giardini C; Politi P; Baronciani D; Angelucci E; Manenti F; Delfini C; Aureli G N Engl J Med; 1987 Apr; 316(17):1050-5. PubMed ID: 3550463 [TBL] [Abstract][Full Text] [Related]
11. Second allogeneic bone marrow transplantation for post-transplant leukemia relapse: results of a survey of 66 cases in 24 Japanese institutes. Kishi K; Takahashi S; Gondo H; Shiobara S; Kanamaru A; Kato S; Hirabayashi N; Moriyama Y; Harada M; Asano S; Hara H; Shibata A Bone Marrow Transplant; 1997 Mar; 19(5):461-6. PubMed ID: 9052912 [TBL] [Abstract][Full Text] [Related]
12. Unrelated donor bone marrow transplantation as treatment for chronic myeloid leukemia: the Spanish experience. The Chronic Myeloid Leukemia Subcommittee of the GETH. Grupo Español de Trasplante Hemopoyético. Carreras E; Tomás JF; Sanz G; Iriondo A; Boqué C; López J; Cabrera R; Sureda A; de Soria VG; Sierra J; Sanz MA; Torres A Haematologica; 2000 May; 85(5):530-8. PubMed ID: 10800172 [TBL] [Abstract][Full Text] [Related]
13. Bone marrow transplantation for transfused patients with severe aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning therapy: long-term follow-up from a single center. Gaziev D; Giardini C; Galimberti M; Lucarelli G; Angelucci E; Polchi P; Baronciani D; Erer B; Sotti G Bone Marrow Transplant; 1999 Aug; 24(3):253-7. PubMed ID: 10455362 [TBL] [Abstract][Full Text] [Related]
14. Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation. Heinzelmann F; Lang PJ; Ottinger H; Faul C; Bethge W; Handgretinger R; Bamberg M; Belka C Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):523-8. PubMed ID: 17869449 [TBL] [Abstract][Full Text] [Related]
15. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation. Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704 [TBL] [Abstract][Full Text] [Related]
16. Bone marrow transplantation from alternative donors for thalassemia: HLA-phenotypically identical relative and HLA-nonidentical sibling or parent transplants. Gaziev D; Galimberti M; Lucarelli G; Polchi P; Giardini C; Angelucci E; Baronciani D; Sodani P; Erer B; Biagi MD; Andreani M; Agostinelli F; Donati M; Nesci S; Talevi N Bone Marrow Transplant; 2000 Apr; 25(8):815-21. PubMed ID: 10808201 [TBL] [Abstract][Full Text] [Related]
17. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia]. Tong XZ; Li J; Tan EX; Zhang GC; Wu XY; Peng AH; Zheng D; Zou WY; Hong WD; Luo SK Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125 [TBL] [Abstract][Full Text] [Related]
18. Allogeneic transplantation of G-CSF mobilized peripheral blood stem cells from unrelated donors: a retrospective analysis. Bornhäuser M; Theuser C; Soucek S; Hölig K; Klingebiel T; Blau W; Fauser A; Runde V; Schwinger W; Rutt C; Ehninger G Haematologica; 2000 Aug; 85(8):839-47. PubMed ID: 10942931 [TBL] [Abstract][Full Text] [Related]
19. Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia. Kröger N; Zabelina T; Sonnenberg S; Krüger W; Renges H; Stute N; Finkenstein F; Mayer U; Holstein K; Fiedler W; Colberg H; Sonnen R; Kuse R; Braumann D; Metzner B; del Valle F; Erttmann R; Kabisch H; Zander AR Bone Marrow Transplant; 2000 Oct; 26(7):711-6. PubMed ID: 11042650 [TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of allogeneic bone marrow transplantation for patients with chronic phase chronic myeloid leukemia prepared with a regimen consisting of cyclophosphamide, cytarabine and single-dose total body irradiation conditioning. Zaretsky Y; Rifkind J; Lockwood G; Tsang R; Kiss T; Hasegawa W; Fyles G; Tejpar I; Loach D; Minden M; Messner H; Lipton JH Bone Marrow Transplant; 2007 Sep; 40(5):423-30. PubMed ID: 17603516 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]